PubRank

C N Oster

Author PubWeight™ 63.41‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Plasmodium falciparum incidence relative to entomologic inoculation rates at a site proposed for testing malaria vaccines in western Kenya. Am J Trop Med Hyg 1994 2.73
2 Visceral infection caused by Leishmania tropica in veterans of Operation Desert Storm. N Engl J Med 1993 2.61
3 Naturally acquired antibodies to sporozoites do not prevent malaria: vaccine development implications. Science 1987 2.11
4 Pancreatitis induced by pentavalent antimonial agents during treatment of leishmaniasis. Clin Infect Dis 1994 2.02
5 Characterization of malaria transmission by Anopheles (Diptera: Culicidae) in western Kenya in preparation for malaria vaccine trials. J Med Entomol 1990 2.02
6 Specific inhibition of lymphocyte-proliferation responses by adherent suppressor cells in diffuse cutaneous leishmaniasis. N Engl J Med 1982 1.68
7 Look-back investigation after human immunodeficiency virus seroconversion in a pediatric dentist. J Infect Dis 1994 1.46
8 Prompt confirmation of Rocky Mountain spotted fever: identification of rickettsiae in skin tissues. J Infect Dis 1976 1.46
9 The threat of infectious diseases in Somalia. N Engl J Med 1993 1.38
10 Visceral leishmaniasis unresponsive to antimonial drugs. III. Successful treatment using a combination of sodium stibogluconate plus allopurinol. Trans R Soc Trop Med Hyg 1985 1.31
11 Human lymphocyte proliferative response to a sporozoite T cell epitope correlates with resistance to falciparum malaria. J Immunol 1989 1.24
12 Activation of macrophages to kill rickettsiae and Leishmania: dissociation of intracellular microbicidal activities and extracellular destruction of neoplastic and helminth targets. Contemp Top Immunobiol 1984 1.20
13 ELISA method for detecting Plasmodium falciparum circumsporozoite antibody. Bull World Health Organ 1989 1.20
14 Impact of transmission intensity and age on Plasmodium falciparum density and associated fever: implications for malaria vaccine trial design. J Infect Dis 1995 1.19
15 Dose- and time-dependent relations between infective Anopheles inoculation and outcomes of Plasmodium falciparum parasitemia among children in western Kenya. Am J Epidemiol 1997 1.14
16 The threat of infectious disease in Americans returning from Operation Desert Storm. N Engl J Med 1991 1.14
17 Isolation of HIV-1 from the blood of seropositive adults: patient stage of illness and sample inoculum size are major determinants of a positive culture. The Walter Reed Retroviral Research Group. J Acquir Immune Defic Syndr 1990 1.11
18 Predicting outcome in malaria: correlation between rate of exposure to infected mosquitoes and level of Plasmodium falciparum parasitemia. Am J Trop Med Hyg 1994 1.10
19 Susceptibility of clinically sensitive and resistant Leishmania to pentavalent antimony in vitro. Am J Trop Med Hyg 1982 1.09
20 Malaria in asplenic mice: effects of splenectomy, congenital asplenia, and splenic reconstitution on the course of infection. Am J Trop Med Hyg 1980 1.08
21 Frequent isolation of HIV-1 from the blood of patients receiving zidovudine (AZT) therapy. N Engl J Med 1989 1.08
22 Laboratory-acquired Rocky Mountain spotted fever. The hazard of aerosol transmission. N Engl J Med 1977 1.04
23 Safety and efficacy of intravenous sodium stibogluconate in the treatment of leishmaniasis: recent U.S. military experience. Clin Infect Dis 1998 1.00
24 Cutaneous leishmaniasis following local trauma: a clinical pearl. Clin Infect Dis 2000 0.99
25 Evaluation in humans of a new, inactivated vaccine for Venezuelan equine encephalitis virus (C-84). J Infect Dis 1979 0.98
26 Plasmodium falciparum gametocytemia in Kenyan children: associations among age, intensity of exposure to transmission, and prevalence and density of subsequent gametocytemia. Am J Trop Med Hyg 1997 0.94
27 Initial clinical evaluation of a new Rocky Mountain spotted fever vaccine of tissue culture origin. J Infect Dis 1978 0.91
28 Isolation of Leishmania donovani from Phlebotomus martini in Baringo district, Kenya. Trans R Soc Trop Med Hyg 1988 0.91
29 Evaluation of promastigote and amastigote antigens in the indirect fluorescent antibody test for American cutaneous leishmaniasis. Am J Trop Med Hyg 1983 0.91
30 Long-term follow-up of symptomatic HIV-infected patients originally randomized to early versus later zidovudine treatment; report of a Veterans Affairs Cooperative Study. VA Cooperative Study Group on AIDS Treatment. J Acquir Immune Defic Syndr Hum Retrovirol 1996 0.90
31 Macrophage activation to kill Leishmania tropica: kinetics of macrophage response to lymphokines that induce antimicrobial activities against amastigotes. J Immunol 1984 0.90
32 Post kala-azar dermal leishmaniasis: the Kenyan experience. East Afr Med J 1991 0.90
33 Prophylactic treatment of Rocky Mountain spotted fever. J Clin Microbiol 1978 0.90
34 Identification of Rickettsia conorii infection by polymerase chain reaction in a soldier returning from Somalia. Clin Infect Dis 1994 0.89
35 Herpes zoster and lymphopenia associated with sodium stibogluconate therapy for cutaneous leishmaniasis. Clin Infect Dis 1998 0.89
36 Post-kala-azar dermal leishmaniasis occurring long after cure of visceral leishmaniasis in Kenya. East Afr Med J 1986 0.88
37 Concurrent infection with Leishmania donovani and Leishmania major in a Kenyan patient: clinical description and parasite characterization. Am J Trop Med Hyg 1991 0.87
38 Suppression of cellular immune responses in guinea pigs infected with spotted fever group rickettsiae. Infect Immun 1978 0.87
39 Leishmania donovani parasites in the nasal secretions, tonsillopharyngeal mucosa, and urine centrifugates of visceral leishmaniasis patients in Kenya. Am J Trop Med Hyg 1993 0.87
40 Pre-exposure rabies immunization with human diploid cell vaccine: decreased antibody responses in persons immunized in developing countries. Am J Trop Med Hyg 1985 0.84
41 Clinical performance of a polymerase chain reaction testing algorithm for diagnosis of HIV-1 infection in peripheral blood mononuclear cells. J Med Virol 1991 0.83
42 Activation of the kallikrein-kinin system in Rocky Mountain spotted fever. Ann Intern Med 1978 0.83
43 Clinical features of inflammatory dermatoses in human immunodeficiency virus type 1 disease and their correlation with Walter Reed stage. Military Medical Consortium for Applied Retroviral Research. J Am Acad Dermatol 1993 0.83
44 Generalized chronic dermatophytosis in patients with human immunodeficiency virus type I infection and CD4 depletion. Arch Dermatol 1991 0.82
45 A retrospective analysis of diseases associated with indeterminate HIV western blot patterns. Mil Med 1991 0.81
46 Hematogenous group B streptococcal osteomyelitis in an adult. South Med J 1984 0.80
47 Effect of human circumsporozoite antibodies in Plasmodium-infected Anopheles (Diptera: Culicidae). J Med Entomol 1989 0.80
48 Failure of amphotericin B lipid complex in the treatment of cutaneous leishmaniasis. Clin Infect Dis 1998 0.80
49 Prolonged recurrence of pentamidine-induced torsades de pointes. Ann Pharmacother 1992 0.79
50 Congenital visceral leishmaniasis: case report. Trans R Soc Trop Med Hyg 1988 0.79
51 Plasmodium falciparum circumsporozoite vaccine immunogenicity and efficacy trial with natural challenge quantitation in an area of endemic human malaria of Kenya. Vaccine 1996 0.79
52 American cutaneous leishmaniasis: a comparison of three sodium stibogluconate treatment schedules. Am J Trop Med Hyg 1985 0.78
53 Comparison of three culture media for isolating Leishmania donovani from splenic aspirates in Kenyan visceral leishmaniasis. East Afr Med J 1984 0.78
54 Intracellular destruction of Leishmania tropica by macrophages activated in vivo with Mycobacterium bovis strain bcg. Adv Exp Med Biol 1983 0.77
55 American cutaneous leishmaniasis: presentation and problems of patient management. Rev Soc Bras Med Trop 1990 0.77
56 Cutaneous leishmaniasis caused by Leishmania tropica in Kenya. Trans R Soc Trop Med Hyg 1987 0.77
57 Mouse foot-pad inoculation as an aid to the isolation of Leishmania spp. from patients. Trans R Soc Trop Med Hyg 1988 0.76
58 An oligonucleotide probe for detecting Plasmodium falciparum: an analysis of clinical specimens from six countries. J Infect Dis 1987 0.76
59 Safety and immunogenicity of a Plasmodium falciparum sporozoite vaccine: boosting of antibody response in a population with prior natural exposure to malaria. Trans R Soc Trop Med Hyg 1991 0.76
60 Isozyme variation in Simulium (Edwardsellum) damnosum s.l. (Diptera: Simuliidae) from Kenya. J Am Mosq Control Assoc 1987 0.76
61 Histopathologic and immunohistochemical findings associated with inflammatory dermatoses in human immunodeficiency virus type 1 disease and their correlation with Walter Reed stage. Military Medical Consortium for Applied Retroviral Research. J Am Acad Dermatol 1993 0.75
62 Iontophoresis of vinblastine into normal skin and for treatment of Kaposi's sarcoma in human immunodeficiency virus-positive patients. The Military Medical Consortium for Applied Retroviral Research. Arch Dermatol 1992 0.75
63 The relationship between outpatient drug costs and disease progression in the human immunodeficiency virus-infected population. The Military Medical Consortium for Applied Retroviral Research. DICP 1991 0.75
64 Diagnostic and therapeutic dilemmas of a large scrotal lesion in an AIDS patient. AIDS Read 2001 0.75
65 Lymph node involvement in leishmaniasis. J Am Acad Dermatol 1985 0.75
66 Early diagnosis of Rocky Mountain spotted fever. Arch Intern Med 1979 0.75
67 Other parasitic diseases found in patients with visceral leishmaniasis. East Afr Med J 1985 0.75
68 Bleomycin sclerotherapy for bilateral pneumothoraces in a patient with AIDS. Ann Intern Med 1990 0.75
69 Fatal pneumococcal septicaemia in an adult with a congenitally small (11.2 gm) spleen. East Afr Med J 1985 0.75
70 Aerosolized pentamidine and Pneumocystis carinii pneumonia: patient compliance and outcomes. Ann Pharmacother 1992 0.75
71 Thiosemicarbazones of 2-acetylpyridine, 2-acetylquinoline, 1- and 3-acetylisoquinoline and related compounds as inhibitors of clinically significant bacteria in vitro. Arzneimittelforschung 1983 0.75